The analysis revealed that LIPT2 amplification was found in more than 7 types of cancers, with Bladder Urothelial Carcinoma (BLCA) having the highest LIPT2 amplification rate (> 15%). This evidence concerns the gene LIPT2 and bladder transitional cell carcinoma.